Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Biomarkers for Assessing Cancer Patients for Treatment

  • Read more about Biomarkers for Assessing Cancer Patients for Treatment
US Application 61/937,075
Filed on 2014-02-07

Biomarkers for NAD(+)-Diphathamide ADP Ribosyl Transferase Sensitivity and Resistance

  • Read more about Biomarkers for NAD(+)-Diphathamide ADP Ribosyl Transferase Sensitivity and Resistance
US Application 62/183,900
Filed on 2015-06-24

Inhibition Of Plasminogen Activator Inhibitor-1 (PAI-1) Activity Mitigates Radiation Fibrosis

  • Read more about Inhibition Of Plasminogen Activator Inhibitor-1 (PAI-1) Activity Mitigates Radiation Fibrosis
US Application 61/867,801
Filed on 2013-08-20

Fulvestrant Improves Immune-mediated Cytotoxic Lysis Of Cancer Cells

  • Read more about Fulvestrant Improves Immune-mediated Cytotoxic Lysis Of Cancer Cells
US Application 62/290,117
Filed on 2016-02-02

Inhibitors Of Prokaryotic Gene Transcription and Uses Thereof

  • Read more about Inhibitors Of Prokaryotic Gene Transcription and Uses Thereof
US Application 62/308,700
Filed on 2016-03-15

Combination Of Histone Deacetylase Inhibitor and Immunotherapy

  • Read more about Combination Of Histone Deacetylase Inhibitor and Immunotherapy
US Application 62/274,946
Filed on 2016-01-05

Method of Sensitizing Cancer Cells To The Cytotoxic Effects of Apoptosis Inducing Ligands in Cancer Treatment

  • Read more about Method of Sensitizing Cancer Cells To The Cytotoxic Effects of Apoptosis Inducing Ligands in Cancer Treatment
US Application 62/292,974
Filed on 2016-02-09

Anti-BCMA Polypeptides and Proteins

  • Read more about Anti-BCMA Polypeptides and Proteins
US Application 62/257,493
Filed on 2015-11-19

Anti-BCMA Polypeptides and Conjugates

  • Read more about Anti-BCMA Polypeptides and Conjugates
US Application 62/255,255
Filed on 2015-11-13

Methods of Producing T Cell Populations Using Prolyl Hydroxylase Domain-Containing Protein Inhibitors

  • Read more about Methods of Producing T Cell Populations Using Prolyl Hydroxylase Domain-Containing Protein Inhibitors
US Application 62/249,645
Filed on 2015-11-02

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 85
  • Page 86
  • Page 87
  • Page 88
  • Page 89
  • Page 90
  • Page 91
  • Page 92
  • Page 93
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health